SenoRx Announces Launch of a New SenoSonix(tm) Model With a Portable Hand-Carry Laptop Ultrasound Component

IRVINE, Calif., Apr 9, 2009 (GlobeNewswire via COMTEX News Network) -- SenoRx, Inc. (Nasdaq:SENO) today announced the launch of an additional model of its SenoSonix(tm) System. Like the original SenoSonix, the new model is an integration of SenoRx's EnCor(r) breast biopsy system with ultrasound imaging. This new version of the device incorporates a microminiaturization ultrasound technology that combines personal computing power and flexibility. The new ultrasound component is designed, developed and manufactured by Terason, a division of Teratech Corporation, based in Burlington, Massachusetts. This versatile and unique ultrasound technology coupled with SenoRx's proprietary EnCor vacuum-assisted biopsy technology results in an attractive alternative model of the SenoSonix System for our customers. The modular design and sophisticated imaging architecture are now available in a reduced footprint with increased portability. The SenoSonix System received 510(k) clearance in October 2007 and CE Mark approval in April 2008.

"Our new SenoSonix model is designed to meet the needs of breast surgeons performing breast biopsy procedures utilizing ultrasound in both their offices and in the hospital surgery suite who wish to have the flexibility of moving the ultrasound component between the two locations," said Lloyd Malchow, SenoRx President and Chief Executive Officer. "The new system may be particularly well suited for markets in Europe and Asia where a significant percentage of biopsy procedures are performed utilizing ultrasound. We are pleased to be working with Terason on this compact portable solution. We will begin introducing this product in the U.S. and in select countries in which we have launched the EnCor breast biopsy system."

source:SeoRx